|
|
|
22.07.26 - 16:33
|
UBS Warns Trump′s 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners (ZeroHedge)
|
|
|
UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners
President Trump will impose a 100% tariff on imported generic drugs starting in August 2028, rising to 200% a year later, unless manufacturers shift production to the US.
"This is done in order to RESHORE Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and Equipment within the stated period of time given to them," Trump wrote on Truth Social late Tuesday.
He continued, "The objective of this Policy is to protect the people of the United States. The Policy on Patented, Branded, or Innovative Drugs, which has been so successful, will remain as is," adding, "Pharmaceutical Facilities are being built, at a level never seen before, all over the United States of America."
Trump's announcement is the latest effort to reshore critical supply chains, and in this case, boost domestic productio...
|
|
|
22.07.26 - 15:01
|
Goldman Sachs Aktie hochgestuft: Gewinnprognosen steigen schneller als der Kurs (Aktiencheck)
|
|
|
London (www.aktiencheck.de) - Goldman Sachs-Aktienanalyse von HSBC:
Die Analysten von HSBC stufen die Aktie von The Goldman Sachs Group Inc. (ISIN: US38141G1040, WKN: 920332, Ticker-Symbol: GOS, NYSE-Symbol: GS) von "reduce" auf "hold" hoch und erhöhen das Kursziel von 834 USD auf 995 USD.
Zur Begründung würden die Analysten auf die verbesserten Gewinnaussichten der Bank sowie die gesunkene Bewertungsmultiplikation verweisen. [mehr]...
|
|
|
|
|
|
|
22.07.26 - 14:30
|
AEGIS Hedging to Be Acquired by Private Equity at Goldman Sachs Alternatives (Business Wire)
|
|
|
Investment alongside the existing AEGIS management team will advance capabilities to enable better decision-making across global commodity marketsTHE WOODLANDS, Texas--(BUSINESS WIRE)--AEGIS Hedging Solutions ("AEGIS" or the "Company"), a leading provider of commodity market intelligence, technology, and market infrastructure, today announced it has entered into a definitive transaction agreement with Private Equity at Goldman Sachs Alternatives. Goldman Sachs Alternatives succeeds Greenbelt Capital Partners and Baird Capital as the Company's institutional investment partner. Financial terms were not disclosed.
Founded in 2013, AEGIS works with 700 commodity producers and consumers, capital providers, and financial counterparties across North America to enable more informed commercial decisions and manage commodity price risk.
With increasingly volatile commodity prices, this partnership will accelerate AEGIS's investment in commodity-focused advisory, technology, artificial intellig...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
